The Effects of ADHD Medication (TEAM) Study: Neurobehavioral Effects of Abrupt Methylphenidate Discontinuation
Phase of Trial: Phase IV
Latest Information Update: 21 Apr 2017
At a glance
- Drugs Methylphenidate (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- Acronyms TEAM
- 26 Jan 2016 Planned End Date changed from 1 Jan 2020 to 1 Jun 2020, as reported by ClinicalTrials.gov.
- 26 Jan 2016 Planned primary completion date changed from 1 Jan 2019 to 1 Jun 2019, as reported by ClinicalTrials.gov.
- 19 Apr 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.